G75850OP

Summary
GlyTouCan ID
G75850OP
IUPAC Condensed
Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc(b1-
Motifs
N-Glycan complex N-acetyllactosamine Type 2 LN
Subsumption Level
Fully-defined saccharide
Monoisotopic Mass
1931.69
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
CarbBank
1745 5377 5435 5481
Organisms
KEGG BRITE Database
KEGG ID
GALAXY
Glucose Units
ODS
12.2
Amide
6.9
Degrading Enzymes
Displaying all 3 entries
Enzyme Substrate Product
α-Fucosidase
G07392QY
G75850OP
α-Sialidase
G75850OP
G36191CD
β-Galactosidase
G75850OP
G90725ZC
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
3b:b-dglc-HEX-1:5
4s:n-acetyl
5b:b-dman-HEX-1:5
6b:a-dman-HEX-1:5
7b:b-dglc-HEX-1:5
8s:n-acetyl
9b:b-dgal-HEX-1:5
10b:a-dman-HEX-1:5
11b:b-dglc-HEX-1:5
12s:n-acetyl
13b:b-dgal-HEX-1:5
14b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
15s:n-acetyl
LIN
1:1d(2+1)2n
2:1o(4+1)3d
3:3d(2+1)4n
4:3o(4+1)5d
5:5o(3+1)6d
6:6o(2+1)7d
7:7d(2+1)8n
8:7o(4+1)9d
9:5o(6+1)10d
10:10o(2+1)11d
11:11d(2+1)12n
12:11o(4+1)13d
13:13o(6+2)14d
14:14d(5+1)15n
WURCS
WURCS=2.0/5,10,9/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1b_1-5][a1122h-1a_1-5][a2112h-1b_1-5][Aad21122h-2a_2-6_5*NCC/3=O]/1-1-2-3-1-4-3-1-4-5/a4-b1_b4-c1_c3-d1_c6-g1_d2-e1_e4-f1_g2-h1_h4-i1_i6-j2
Literature
Displaying entry 11 - 11 of 11 in total
PubMed ID Title First Author Publication Date Source
7309709 Studies on the Structures of the Carbohydrate Moiety of Human Prothrombin1 Mizuochi T 1981 Oct
  • GlyGen
  • PubChem

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.4.0

Last updated: December 8, 2025